engleski

Is Effect of Low-Level Laser Therapy in Patients with Burning Mouth Syndrome Result of a Placebo?

Forty female participants were included in this study. All had BMS and their average age was 68 years (range 57-85 years). Participants were randomly allocated. In 20 BMS patients, red diode laser with emission of 685nm was applied five times a week during 2 weeks. Another 20 patients with BMS served as a control group and were treated by the same laser, which was switched off. This investigation was single-blinded placcebo-controlled. Burning intensity was recorded by use of visual analogue scale (VAS) every day during 10 days of therapy. LLLT decreased symptom intensity in BMS patients as seen by VAS, but also the symptom intensity decreased in the same manner in the placebo group as wel, where device was switched off.

Low-Level Laser Therapy; Burning Mouth Syndrome; Placebo

nije evidentirano